Our initial strategy was the comparison of the protein levels for all 50 AML patients and the eight normal CD34+ bone marrow cell populations by using Welch’s t-test with Benjamini–Hochberg correction (i.e., FDR < 0.01) as described in Section 3.1. The gene discussed is CD34; the disease is acute myeloid leukemia.